Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Nucleic Acids
100%
Clinical Application
100%
Lipid Nanoparticles
100%
Genome Editing
100%
CRISPR-Cas
40%
Prime Editing
40%
Clinical Translation
20%
In Vivo Gene Delivery
20%
Double-strand Breaks
20%
Therapeutic Goals
20%
Targeting Ligands
20%
Delivery Mechanisms
20%
Efficient Delivery
20%
Single Guide RNA (sgRNA)
20%
Genetic Disease
20%
RNA Delivery
20%
FDA-approved Drugs
20%
Safe Delivery
20%
Nanoparticle Structure
20%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
20%
Lipid Nanoparticle Formulations
20%
CRISPR-Cas Technology
20%
Base Editing
20%
Medicine and Dentistry
Nanoparticle
100%
Nucleic Acid
100%
Genome Editing
100%
Clustered Regularly Interspaced Short Palindromic Repeat
66%
Diseases
33%
Malignant Neoplasm
16%
Messenger RNA
16%
Base
16%
Genetic Disorder
16%
in Vivo Gene Transfer
16%
Guide RNA
16%
Pharmacology, Toxicology and Pharmaceutical Science
Solid Lipid Nanoparticle
100%
Nucleic Acid
100%
Diseases
33%
Malignant Neoplasm
16%
Messenger RNA
16%
Base
16%
Genetic Disorder
16%
Guide RNA
16%
Material Science
Nucleic Acid
100%
Solid Lipid Nanoparticle
100%
Gene Therapy
16%